Plasma orexin A increases at emergence from sevoflurane-fentanyl anesthesia in patients undergoing ophthalmologic surgery

Neuroscience Letters

Volumn 482, Issue 3, 2010, Pages 212-215

  Kushikata, Tetsuya ^a   Yoshida, Hitoshi ^a   Kudo, Mihoko ^a   Kudo, Tsuyoshi ^a   Hirota, Kazuyoshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Catecholamine; Cortisol; Hypothalamic pituitary adrenal axis; Orexin A; Sevoflurane

Indexed keywords

ADRENALIN; FENTANYL; HYDROCORTISONE; NORADRENALIN; OREXIN A; PROPOFOL; SEVOFLURANE; VECURONIUM;

ADULT; ANESTHESIA INDUCTION; ARTERIAL BLOOD; ARTICLE; BISPECTRAL INDEX; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; ELECTIVE SURGERY; EYE SURGERY; FEMALE; GENERAL ANESTHESIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; SURGICAL PATIENT;

ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPINEPHRINE; FEMALE; FENTANYL; HUMANS; HYDROCORTISONE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; METHYL ETHERS; MIDDLE AGED; NEUROPEPTIDES; NOREPINEPHRINE; OPHTHALMOLOGIC SURGICAL PROCEDURES;

EID: 77955927473     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.07.037     Document Type: Article

References (22)

1. Dong H., Niu J., Su B., Zhu Z., Lv Y., Li Y., Xiong L. Activation of orexin signal in basal forebrain facilitates the emergence from sevoflurane anesthesia in rat. Neuropeptides 2009, 43:179-185.
2. He Y., Kudo M., Kudo T., Kushikata T., Li E., Hirota K. The effects of benzodiazepines on orexinergic systems in rat cerebrocortical slices. Anesth. Analg. 2007, 104:338-340.
3. Higuchi S., Usui A., Murasaki M., Matsushita S., Nishioka N., Yoshino A., Matsui T., Muraoka H., Ishizuka Y., Kanba S., Sakurai T. Plasma orexin-A is lower in patients with narcolepsy. Neurosci. Lett. 2002, 318:61-64.
4. Hirota K., Kushikata T. Central noradrenergic neurones and the mechanism of general anaesthesia. Br. J. Anaesth. 2001, 87:811-813.
5. Ihn C.H., Joo J.D., Choi J.W., Kim D.W., Jeon Y.S., Kim Y.S., Jung H.S., Kwon S.Y. Comparison of stress hormone response, interleukin-6 and anaesthetic characteristics of two anaesthetic techniques: volatile induction and maintenance of anaesthesia using sevoflurane versus total intravenous anaesthesia using propofol and remifentanil. J. Int. Med. Res. 2009, 37:1760-1771.
6. Kastin A.J., Akerstrom V. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J. Pharmacol. Exp. Ther. 1999, 289:219-223.
7. Kelz M.B., Sun Y., Chen J., Cheng Meng Q., Moore J.T., Veasey S.C., Dixon S., Thornton M., Funato H., Yanagisawa M. An essential role for orexins in emergence from general anesthesia. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1309-1314.
8. Kirchgessner A.L. Orexins in the brain-gut axis. Endocr. Rev. 2002, 23:1-15.
9. Kuru M., Ueta Y., Serino R., Nakazato M., Yamamoto Y., Shibuya I., Yamashita H. Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 2000, 11:1977-1980.
10. Kushikata T., Hirota K., Yoshida H., Kudo M., Lambert D.G., Smart D., Jerman J.C., Matsuki A. Orexinergic neuron and barbiturate anesthesia. Neuroscience 2003, 121:855-863.
11. Kushikata T., Yoshida H., Kudo M., Kudo T., Hirota K. Changes in plasma orexin A during propofol-fentanyl anaesthesia in patients undergoing eye surgery. Br. J. Anaesth. 2010, 104:723-727.
12. Ledowski T., Bein B., Hanss R., Paris A., Fudickar W., Scholz J., Tonner P.H. Neuroendocrine stress response and heart rate variability: a comparison of total intravenous versus balanced anesthesia. Anesth. Analg. 2005, 101:1700-1705.
13. Marana E., Scambia G., Colicci S., Maviglia R., Maussier M.L., Marana R., Proietti R. Leptin and perioperative neuroendocrine stress response with two different anaesthetic techniques. Acta Anaesthesiol. Scand. 2008, 52:541-546.
14. Mignot E., Lammers G.J., Ripley B., Okun M., Nevsimalova S., Overeem S., Vankova J., Black J., Harsh J., Bassetti C., Schrader H., Nishino S. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol. 2002, 59:1553-1562.
15. Ouedraogo R., Näslund E., Kirchgessner A.L. Glucose regulates the release of orexin-A from the endocrine pancreas. Diabetes 2003, 52:111-117.
16. Rudd B.T., Sampson P., Brook B.N. A new fluorimetric method of plasma cortisol assay with a study of pituitary-adrenal function using metyrapone (SU 4885). J. Endocrinol. 1963, 27:317-325.
17. Russell S.H., Small C.J., Dakin C.L., Abbott C.R., Morgan D.G., Ghatei M.A., Bloom S.R. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J. Neuroendocrinol. 2001, 13:561-566.
18. Sakurai S., Nishijima T., Takahashi S., Yamauchi K., Arihara Z., Takahashi K. Low plasma orexin-A levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome. Chest 2005, 127:731-737.
19. Spinazzi R., Andreis P.G., Rossi G.P., Nussdorfer G.G. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol. Rev. 2006, 58:46-57.
20. Taheri S., Mahmoodi M., Opacka-Juffry J., Ghatei M.A., Bloom S.R. Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Lett. 1999, 457:157-161.
21. Tose R., Kushikata T., Yoshida H., Kudo M., Furukawa K., Ueno S., Hirota K. Orexin A decreases ketamine-induced anesthesia time in the rat: the relevance to brain noradrenergic neuronal activity. Anesth. Analg. 2009, 108:491-495.
22. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., de Lecea L. Interaction between the corticotrophin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 2004, 24:11439-11448.